Pharmacelera

Executive Summary

Pharmacelera is a Spanish biotechnology company founded in 2014 that combines quantum mechanics, AI, and computational chemistry to accelerate drug discovery. Its proprietary CADD platform enables efficient exploration of ultra-large chemical spaces, identifying novel, synthesizable compounds for targets. The company offers both software and services to pharma and biotech clients, aiming to reduce R&D costs and time. With a lean approach from target identification to lead optimization, Pharmacelera addresses the high attrition rates in early-stage drug development. While still in the pre-clinical stage, the company’s technology has potential to transform small-molecule discovery.

Upcoming Catalysts (preview)

• Q1 2027Strategic partnership with a top pharma company50% success
• Q3 2026Release of next-generation CADD platform with enhanced AI capabilities70% success
• Q4 2026Series A funding round to expand commercial operations60% success